Clinical Aspects of Hepatocellular Carcinoma in Japan
Author:
Open Access
- 1 January 2006
- journal article
- review article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 45 (5) , 229-233
Abstract
HCC in Japan has very different characteristics from that in other Asian countries. Because, among the Japanese HCC patients approximately 80% of the patients are HCV positive and they are aged over 60 years old. On the other hand, in many Asian countries HBVpositive HCC patients are dominant and their age is younger than the Japanese patients. Early diagnosis of HCC is mainly performed by means of imaging diagnostic technique such as abdominal ultrasonography, dynamic CT, dynamic MRI and CT angiography. If small HCC less than 3 cm in diameter is found and liver function is well preserved, local ablation therapy or surgical treatment promises better than 5 years survival (over 60%). While, TAE or TACE is performed in cases of HCC larger than 3 cm in size, if liver failure is not complicated. In advanced HCC cases with multiple tumors, arterial infusion of anticancer drug has been applied. However, its efficacy is not estimated. Chemoprevention is another modality for HCC. Eradication of HCV with an antiviral agent has proven to prevent hepatocarcinogenesis. As for chemoprevention of HCC, some trials are on going in Japan.Keywords
This publication has 25 references indexed in Scilit:
- Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core proteinGastroenterology, 2002
- Hepatitis C Virus Core Protein Activates the Mapk/Erk Cascade Synergistically With Tumor Promoter Tpa, But Not With Epidermal Growth Factor or Transforming Growth Factor αHepatology, 2000
- The Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Cascade Activation Is a Key Signalling Pathway Involved in the Regulation of G1 Phase Progression in Proliferating HepatocytesMolecular and Cellular Biology, 1999
- Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinomaHepatology, 1998
- Hepatitis B Virus X Gene Expression Is Activated by X Protein but Repressed by p53 Tumor Suppressor Gene Product in the Transient Expression SystemVirology, 1996
- Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in JapanHepatology, 1995
- The MAPK signaling cascadeThe FASEB Journal, 1995
- HBx gene of hepatitis B virus induces liver cancer in transgenic miceNature, 1991
- Androgen receptors in hepatocellular carcinoma and surrounding parenchymaGastroenterology, 1985
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular CarcinomaNew England Journal of Medicine, 1981